Khadijah K Breathett1, Haolin Xu2, Nancy K Sweitzer3, Elizabeth Calhoun4, Roland A Matsouaka2, Clyde W Yancy5, Gregg C Fonarow6, Adam D DeVore7, Deepak L Bhatt8, Pamela N Peterson9. 1. Division of Cardiovascular Medicine, Sarver Heart Center, University of Arizona, Tucson, AZ. Electronic address: dijikb@gmail.com. 2. Department of Biostatistics and Bioinformatics, Duke University, Durham, NC. 3. Division of Cardiovascular Medicine, Sarver Heart Center, University of Arizona, Tucson, AZ. 4. Center for Population Science and Discovery, University of Arizona, Tucson, AZ. 5. Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL. 6. Division of Cardiology, University of California Los Angeles, CA. 7. Division of Cardiology, Duke University, Durham, NC. 8. Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA. 9. Division of Cardiology, University of Colorado, Anschutz Medical Campus, Aurora, CO; Division of Cardiology, Denver Health Medical Center, Denver, CO.
Abstract
BACKGROUND: Uninsurance is a known contributor to racial/ethnic health inequities. Insurance is often needed for prescriptions and follow-up appointments. Therefore, we determined whether the Affordable Care Act(ACA) Medicaid Expansion was associated with increased receipt of guideline-directed medical treatment(GDMT) at discharge among patients hospitalized with heart failure(HF) by race/ethnicity. METHODS: Using Get With The Guidelines-HF registry, logistic regression was used to assess odds of receiving GDMT(HF medications; education; follow-up appointment) in early vs non-adopter states before(2012 - 2013) and after ACA Medicaid Expansion(2014 - 2019) within each race/ethnicity, accounting for patient-level covariates and within-hospital clustering. We tested for an interaction(p-int) between GDMT and pre/post Medicaid Expansion time periods. RESULTS: Among 271,606 patients(57.5% early adopter, 42.5% non-adopter), 65.5% were White, 22.8% African American, 8.9% Hispanic, and 2.9% Asian race/ethnicity. Independent of ACA timing, Hispanic patients were more likely to receive all GDMT for residing in early adopter states compared to non-adopter states (P <.0001). In fully-adjusted analyses, ACA Medicaid Expansion was associated with higher odds of receipt of ACEI/ARB/ARNI in Hispanic patients [before ACA:OR 0.40(95%CI:0.13,1.23); after ACA:OR 2.46(1.10,5.51); P-int = .0002], but this occurred in the setting of an immediate decline in prescribing patterns, particularly among non-adopter states, followed by an increase that remained lowest in non-adopter states. The ACA was not associated with receipt of GDMT for other racial/ethnic groups. CONCLUSIONS: Among GWTG-HF hospitals, Hispanic patients were more likely to receive all GDMT if they resided in early adopter states rather than non-adopter states, independent of ACA Medicaid Expansion timing. ACA implementation was only associated with higher odds of receipt of ACEI/ARB/ARNI in Hispanic patients. Additional steps are needed for improved GDMT delivery for all.
BACKGROUND: Uninsurance is a known contributor to racial/ethnic health inequities. Insurance is often needed for prescriptions and follow-up appointments. Therefore, we determined whether the Affordable Care Act(ACA) Medicaid Expansion was associated with increased receipt of guideline-directed medical treatment(GDMT) at discharge among patients hospitalized with heart failure(HF) by race/ethnicity. METHODS: Using Get With The Guidelines-HF registry, logistic regression was used to assess odds of receiving GDMT(HF medications; education; follow-up appointment) in early vs non-adopter states before(2012 - 2013) and after ACA Medicaid Expansion(2014 - 2019) within each race/ethnicity, accounting for patient-level covariates and within-hospital clustering. We tested for an interaction(p-int) between GDMT and pre/post Medicaid Expansion time periods. RESULTS: Among 271,606 patients(57.5% early adopter, 42.5% non-adopter), 65.5% were White, 22.8% African American, 8.9% Hispanic, and 2.9% Asian race/ethnicity. Independent of ACA timing, Hispanic patients were more likely to receive all GDMT for residing in early adopter states compared to non-adopter states (P <.0001). In fully-adjusted analyses, ACA Medicaid Expansion was associated with higher odds of receipt of ACEI/ARB/ARNI in Hispanic patients [before ACA:OR 0.40(95%CI:0.13,1.23); after ACA:OR 2.46(1.10,5.51); P-int = .0002], but this occurred in the setting of an immediate decline in prescribing patterns, particularly among non-adopter states, followed by an increase that remained lowest in non-adopter states. The ACA was not associated with receipt of GDMT for other racial/ethnic groups. CONCLUSIONS: Among GWTG-HF hospitals, Hispanic patients were more likely to receive all GDMT if they resided in early adopter states rather than non-adopter states, independent of ACA Medicaid Expansion timing. ACA implementation was only associated with higher odds of receipt of ACEI/ARB/ARNI in Hispanic patients. Additional steps are needed for improved GDMT delivery for all.
Authors: Paul J Hauptman; Zackary D Goff; Andrija Vidic; John T Chibnall; Barry E Bleske Journal: JAMA Intern Med Date: 2017-01-01 Impact factor: 21.873
Authors: Khadijah Breathett; Jacqueline Jones; Hillary D Lum; Dawn Koonkongsatian; Christine D Jones; Urvi Sanghvi; Lilian Hoffecker; Marylyn McEwen; Stacie L Daugherty; Irene V Blair; Elizabeth Calhoun; Esther de Groot; Nancy K Sweitzer; Pamela N Peterson Journal: J Racial Ethn Health Disparities Date: 2018-03-05
Authors: Khadijah Breathett; Wenhui G Liu; Larry A Allen; Stacie L Daugherty; Irene V Blair; Jacqueline Jones; Gary K Grunwald; Marc Moss; Tyree H Kiser; Ellen Burnham; R William Vandivier; Brendan J Clark; Eldrin F Lewis; Sula Mazimba; Catherine Battaglia; P Michael Ho; Pamela N Peterson Journal: JACC Heart Fail Date: 2018-05 Impact factor: 12.035
Authors: Khadijah Breathett; Erika Yee; Natalie Pool; Megan Hebdon; Janice D Crist; Ryan H Yee; Shannon M Knapp; Sade Solola; Luis Luy; Kathryn Herrera-Theut; Leanne Zabala; Jeff Stone; Marylyn M McEwen; Elizabeth Calhoun; Nancy K Sweitzer Journal: JAMA Netw Open Date: 2020-07-01
Authors: Laxmi S Mehta; Kara Fisher; Anne K Rzeszut; Rebecca Lipner; Stephanie Mitchell; Michael Dill; David Acosta; William J Oetgen; Pamela S Douglas Journal: JAMA Cardiol Date: 2019-10-01 Impact factor: 14.676
Authors: Paul A Heidenreich; Gregg C Fonarow; Khadijah Breathett; Corrine Y Jurgens; Barbara A Pisani; Bunny J Pozehl; John A Spertus; Kenneth G Taylor; Jennifer T Thibodeau; Clyde W Yancy; Boback Ziaeian Journal: Circ Cardiovasc Qual Outcomes Date: 2020-11-02
Authors: Senthil Selvaraj; Gregg C Fonarow; Shubin Sheng; Roland A Matsouaka; Adam D DeVore; Paul A Heidenreich; Adrian F Hernandez; Clyde W Yancy; Deepak L Bhatt Journal: J Am Heart Assoc Date: 2018-03-30 Impact factor: 5.501
Authors: Graham H Smith; Supriya Shore; Larry A Allen; David W Markham; Andrea R Mitchell; Miranda Moore; Alanna A Morris; Candace D Speight; Neal W Dickert Journal: J Am Heart Assoc Date: 2019-01-08 Impact factor: 5.501